# Beryl Drugs Ltd (BERLDRG)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹20.8
Day Change: +2.17%
52W High: ₹30
52W Low: ₹15.92
Market Cap: ₹11 Cr

## Valuation
P/E: 705
P/B: 0.99
EPS: ₹0.03
Book Value: ₹21.28
Dividend Yield: 0%

## Returns
1Y Return: 11.65%

## Profitability
ROE: 11.11%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Beryl Drugs Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Beryl Drugs Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: PROCEEDINGS OF EGM
- Quarterly Report: ANNOUNCEMENT UBDER REGULATION 44 VOTING RESULTS OF EGM HELD ON 11TH MAY 2026
- BSE Filing: PROCEEDINGS OF EGM

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-25T05:00:19.494Z
Price History Updated: 2026-05-25T05:00:21.901Z
Latest Price History Date: 2026-05-25
Technicals Updated: 2026-05-25T05:00:21.901Z
Quant Updated: 2026-05-25T05:00:21.901Z
Sentiment Updated: 2026-05-25T05:00:21.901Z
Financials Status: current
Financials Updated: 2026-05-18T16:30:02.025Z
Financials Last Attempt: 2026-05-18T16:30:02.025Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2022)
Revenue: ₹14 Cr
Operating Profit: ₹-1 Cr (OPM -4.53%)
Net Profit: ₹-1 Cr
Tax: ₹0 Cr

## Annual P&L History
FY 2022: Rev ₹14Cr | PAT ₹-1Cr | OPM -4.53%
FY 2023: Rev ₹27Cr | PAT ₹1Cr | OPM 4.46%
FY 2024: Rev ₹26Cr | PAT ₹1Cr | OPM 4.45%

## Balance Sheet (FY 2022)
Total Assets: ₹18 Cr
Total Liabilities: ₹11 Cr
Borrowings: ₹5 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/berldrg
Disclaimer: For research and education only. Not investment advice.